AI startup Whiterabbit exits stealth mode to announce FDA-cleared breast density software, new CEO

Artificial intelligence firm Whiterabbit exited the startup’s stealth phase of secrecy Tuesday to introduce a new CEO and FDA-cleared breast density software.

Radiologist Alexander Sardiña, MD, brings 20 years of experience to the role, previously serving as chief medical officer of Solis Mammography and CMO/CEO of Houston breast imaging provider Covia Health.

Whiterabbit also recently earned U.S. Food and Drug Administration clearance for its first medical software, WRDensity. The product provides rads with objective data to quantify the level of dense tissue. The Santa Clara, California-based firm has raised some $49 million in funding and inked a partnership with RadNet in 2019 hoping to help the imaging center operator boost adherence.

“Increasing the rate of compliance for annual screenings is one of the most important levers for catching cancer early and reducing the rate of late-stage diagnosis,” Sardiña said in a statement.